Why patients choose prostatectomy or brachytherapy for localized prostate cancer: Results of a descriptive survey

Urology

Volumn 61, Issue 2, 2003, Pages 402-407

  Hall, Joshua D ^a   Boyd, James C ^a   Lippert, Marguerite C ^a   Theodorescu, Dan ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PALLADIUM 103;

ADULT; AGED; ARTICLE; BEAM THERAPY; BLADDER DYSFUNCTION; BRACHYTHERAPY; CANCER EPIDEMIOLOGY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; CONVALESCENCE; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDICAL SPECIALIST; MONOTHERAPY; MOTIVATION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE SURGERY; PROSTATECTOMY; QUESTIONNAIRE; RISK; SEXUAL DYSFUNCTION; STATISTICAL ANALYSIS; URINE INCONTINENCE;

EID: 0037322658     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)02162-3     Document Type: Article

References (21)

1. Greenlee R.T., Murray T., Bolden S., et al. Cancer statistics, 2000. CA Cancer J Clin. 50:2000;7-33.
2. Mazur D.J., Hickam D.H. Patient preferences for management of localized prostate cancer. West J Med. 165:1996;26-30.
3. Mazur D.J., Merz J.F. How older patients' treatment preferences are influenced by disclosures about therapeutic uncertainty surgery versus expectant management for localized prostate cancer . J Am Geriatr Soc. 44:1996;934-937.
4. Montie J.E. Counseling the patient with localized prostate cancer. Urology. 43:1994;36-40.
5. Holmboe E.S., Concato J. Treatment decisions for localized prostate cancer asking men what's important . J Gen Intern Med. 15:2000;694-701.
6. Mazur D.J., Merz J.F. Older patients' willingness to trade off urologic adverse outcomes for a better chance at five-year survival in the clinical setting of prostate cancer. J Am Geriatr Soc. 43:1995;979-984.
7. Cassileth B.R., Zupkis R.V., Sutton-Smith K., et al. Information and participation preferences among cancer patients. Ann Intern Med. 92:1980;832-836.
8. Chaitchik S., Kreitler S., Shaked S., et al. Doctor-patient communication in a cancer ward. J Cancer Educ. 7:1992;41-54.
9. Sutherland H.J., Llewellyn-Thomas H.A., Lockwood G.A., et al. Cancer patients their desire for information and participation in treatment decisions . J R Soc Med. 82:1989;260-263.
10. Grignon D.J., Sakr W.A. Pathologic staging of prostate carcinoma what are the issues? Cancer. 78:1996;337-340.
11. Gleason D.F., Mellinger G.T. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol. 111:1974;58-64.
12. O'Rourke M.E. Narrowing the options the process of deciding on prostate cancer treatment . Cancer Invest. 17:1999;349-359.
13. O'Rourke M.E., Germino B.B. Prostate cancer treatment decisions a focus group exploration . Oncol Nurs Forum. 25:1998;97-104.
14. Krupski T., Petroni G.R., Bissonette E.A., et al. Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer. Urology. 55:2000;736-742.
15. Fowler F.J. Jr, Barry M.J., Lu-Yao G., et al. Outcomes of external-beam radiation therapy for prostate cancer a study of Medicare beneficiaries in three Surveillance, Epidemiology, and End Results areas . J Clin Oncol. 14:1996;2258-2265.
16. Lim A.J., Brandon A.H., Fiedler J., et al. Quality of life radical prostatectomy versus radiation therapy for prostate cancer . J Urol. 154:1995;1420-1425.
17. Shrader-Bogen C.L., Kjellberg J.L., McPherson C.P., et al. Quality of life and treatment outcomes prostate carcinoma patients' perspectives after prostatectomy or radiation therapy . Cancer. 79:1997;1977-1986.
18. Robinson J.W., Dufour M.S., Fung T.S. Erectile functioning of men treated for prostate carcinoma. Cancer. 79:1997;538-544.
19. Feldman-Stewart D., Brundage M.D., Hayter C., et al. What prostate cancer patients should know variation in professionals' opinions . Radiother Oncol. 49:1998;111-123.
20. Feldman-Stewart D., Brundage M.D., Hayter C., et al. What questions do patients with curable prostate cancer want answered? Med Decis Making. 20:2000;7-19.
21. Feldman-Stewart D., Brundage M.D., Nickel J.C., et al. The information required by patients with early-stage prostate cancer in choosing their treatment. BJU Int. 87:2001;218-223.